IKKβ inhibitors are well-documented to selectively kill ABC-DLBCLs33 and, thus we wanted to determine whether iNUB also affected pathological NF-κB signaling that results from uncontrolled antigen signaling in these lymphoma cells. This evidence concerns the gene NFKB1 and lymphoma.